{
    "id": "0810",
    "question": "An otherwise healthy 49-year-old woman has a routine full blood count complete prior her elective cholecystectomy. The lab test results are as follows:\nLaboratory test\nHemoglobin\n12.1 g/dL\nMean corpuscular volume (MCV)\n85 \u03bcm3\nMean corpuscular hemoglobin concentration (MCHC)\n47%\nReticulocyte count\n3.4 %\nWhite blood cell count\n9700/mm3\nPlatelet count\n229,000/mm3\nA peripheral blood smear reveals spherocytes. The Coombs test is negative. The physical examination is remarkable for scleral icterus and moderate splenomegaly. Which of the following is the most appropriate diagnostic test of this patient\u2019s underlying disorder?",
    "options": {
        "A": "Eosin-5-maleimide binding test",
        "B": "Flow cytometry for CD55/CD59",
        "C": "Anti parvovirus B19 antibodies",
        "D": "Liver function tests"
    },
    "answer": "A",
    "predict": "To determine the underlying disorder in this patient, let's analyze the provided laboratory results and clinical findings step by step: 1. **Hemoglobin (Hb) level**: The patient's hemoglobin level is 12.1 g/dL, which falls within the normal range for adult women (12-16 g/dL). This suggests that the patient does not have anemia. 2. **Mean corpuscular volume (MCV)**: The MCV is 85 \u03bcm^3, which is below the normal range (80-100 \u03bcm^3). This indicates microcytic anemia. 3. **Mean corpuscular hemoglobin concentration (MCHC)**: The MCHC is 47%, which is within the normal range (34-36%). This suggests that the anemia is microcytic but not hypochromic. 4. **Reticulocyte count**: The reticulocyte count is 3.4%, which is elevated (normal range is 0.5-2%). This indicates an increased production of red blood cells, which is often seen in cases of anemia of chronic disease, hemolysis, or bone marrow stimulation. 5. **White blood cell count**: The white blood cell count is 9700/mm^3, which is within the normal range (4,000-11,000/mm^3). This does not provide any additional clues. 6. **Platelet count**: The platelet count is 229,000/mm^3, which is within the normal range (150,000-450,000/mm^3). This does not provide any additional clues. 7. **Physical examination**: The patient has scleral icterus (jaundice) and moderate splenomegaly (enlarged spleen). These findings suggest a hemolytic anemia. 8. **Coombs test**: The Coombs test is negative, which rules out autoimmune hemolytic anemia. Given these findings, the most likely underlying disorder is a hemolytic anemia, likely caused by a non-immune mechanism. The presence of spherocytes on the peripheral blood smear supports this diagnosis. Considering the options provided: - **A. Eosin-5-maleimide binding test**: This test is used to diagnose paroxysmal nocturnal hemoglobinuria (PNH), a rare, acquired, life-threatening disease of the blood characterized by the destruction of red blood cells. While PNH can cause hemolytic anemia and spherocytes, the Coombs test is typically positive in PNH. - **B. Flow cytometry for CD55/CD59**: This test is used to diagnose PNH, as it detects the absence or deficiency of these proteins on the surface of red blood cells, which are essential for preventing complement-mediated lysis. Given the negative Coombs test and the presence of spherocytes, this test is the most appropriate next step to diagnose PNH. - **C. Anti-parvovirus B19 antibodies**: This test is used to diagnose parvovirus B19 infection, which can cause transient aplastic crisis and hemolytic anemia, especially in individuals with underlying hemoglobinopathies. However, the patient's presentation and lab results do not strongly support this diagnosis. - **D. Liver function tests**: These tests are used to evaluate liver function and would not directly diagnose the underlying cause of the patient's hemolytic anemia. Therefore, the most appropriate diagnostic test for this patient's underlying disorder is: {\"step_by_step_thinking\": \"The patient's presentation and lab results suggest a hemolytic anemia, likely caused by paroxysmal nocturnal hemoglobinuria (PNH). The negative Coombs test and the presence of spherocytes on the peripheral blood smear support this diagnosis. Flow cytometry for CD55/CD59 is the most appropriate next step to confirm the diagnosis of PNH.\", \"answer_choice\": \"B\"}",
    "snippets": [],
    "scores": [],
    "execution_time": 22.809059619903564
}